Figure 3. Relationship between volume of reactive astrogliosis and prognosis in patients with glioblastoma and cancer stem cells (IMAGE)
Caption
A. Immunofluorescence images showing GFAP, Ki-67, and CD133 in the peri-tumoral region of glioblastoma patients.
B. The proportion of GFAP+ and/or CD133+ in Ki-67+ cells in glioblastoma patients.
C. The 11C-acetate uptake area beyond the contrast-enhanced MRI was defined as VolumeACE-MRI.
D. Kaplan–Meier Survival analysis showed significant differences in progression-free survival (PFS) between the two groups with a VolumeACE-MRI cutoff value of > 5.06cc.
E. Kaplan–Meier Survival analysis also showed significant differences in overall survival (OS) between the two groups with a VolumeACE-MRI cutoff value of > 5.06cc.
Credit
Institute for Basic Science
Usage Restrictions
Attribution Required
License
Original content